News Article

FDA seeks removal of opioid painkiller from the market


Thursday, June 8, 2017

by Washington Post

The Food and Drug Administration on Thursday asked a drug company to remove its opioid pain medication from the market, the first time the agency has made such a request because of the public health consequences of abuse.

The agency concluded after an extensive review of Endo Pharmaceuticals’ Opana ER that the “benefits of the drug may no longer outweigh its risks.” The company reformulated the drug in 2012 to make it more difficult to snort, but the FDA said that move actually led to more injections — and a major HIV outbreak.

https://www.washingtonpost.com/national/health-science/fda-seeks-removal-of-opioid-painkiller-from-the-market/2017/06/08/590aa418-4c8c-11e7-9669-250d0b15f83b_story.html?hpid=hp_hp-more-top-stories_desktop-drugdeaths-730am%3Ahomepage%2Fstory&utm_term=.19064986da9a